Category:David McDonald of New Haven CT (US)

David McDonald of New Haven CT (US)

Executive Summary

David McDonald of New Haven CT (US) is an inventor who has filed 2 patents. Their primary areas of innovation include the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds (2 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (2 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (2 patents), and they have worked with companies such as YALE UNIVERSITY (2 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• A61K47/55 (the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds): 2 patents
• A61K47/545 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
• A61K47/60 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
• A61K47/65 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61P25/00 (Drugs for disorders of the nervous system): 1 patents
• A61K47/64 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers): 1 patents
• A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 1 patents

Companies

List of Companies

• YALE UNIVERSITY: 2 patents

Collaborators

• David Spiegel of New Haven CT (US) (2 collaborations)
• Rebecca Howell of New Haven CT (US) (2 collaborations)